The decellularized vascular allograft as an experimental platform for developing a biocompatible small-diameter graft conduit in a rat surgical model

Yonsei Medical Journal

Volumn 52, Issue 2, 2011, Pages 227-233

  Hwang, Seong Jun ^a   Kim, Seong Who ^a   Choo, Suk Jung ^a   Lee, Byoung Wook ^a   Im, I rang ^a   Yun, Hye Joo ^a   Lee, Sang Kwon ^c   Song, Hyun ^b   Cho, Won Chul ^a   Lee, Jae Won ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c Pusan National University School of Medicine   (South Korea)

Author keywords

Animal model; Rat; Tissue engineering; Vessel

Indexed keywords

ACTIN; CD31 ANTIGEN; COLLAGEN; EOSIN; HEMATOXYLIN; VON WILLEBRAND FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA WALL; ARTICLE; BLOOD VESSEL GRAFT; ELASTIC FIBER; ENDOTHELIUM CELL; FEMALE; IMMUNITY; IMMUNOHISTOCHEMISTRY; NONHUMAN; RAT; TISSUE ENGINEERING; VASCULAR TISSUE;

ANIMALS; AORTA, ABDOMINAL; BIOCOMPATIBLE MATERIALS; DISEASE MODELS, ANIMAL; FEMALE; GRAFT SURVIVAL; RATS; RATS, SPRAGUE-DAWLEY; TISSUE ENGINEERING; TRANSPLANTATION, HOMOLOGOUS;

EID: 79952810639     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2011.52.2.227     Document Type: Article

References (25)

1. Fitzgibbon GM, Kafka HP, Leach AJ, Keon WJ, Hooper GD, Burton JR. Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years. J Am Coll Cardiol 1996;28: 616-26.
2. Taylor LM Jr, Edwards JM, Porter JM. Present status of reversed vein bypass grafting: five-year results of a modern series. J Vasc Surg 1990;11:193-205.
3. Veith FJ, Gupta SK, Ascer E, White-Flores S, Samson RH, Scher LA, et al. Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial reconstructions. J Vasc Surg 1986;3:104-14.
4. Klinkert P, Post PN, Breslau PJ, van Bockel JH. Saphenous vein versus PTFE for above-knee femoropopliteal bypass. A review of the literature. Eur J Vasc Endovasc Surg 2004;27:357-62.
5. Kashyap VS, Ahn SS, Quinones-Baldrich WJ, Choi BU, Dorey F, Reil TD, et al. Infrapopliteal-lower extremity revascularization with prosthetic conduit: a 20-year experience. Vasc Endovascular Surg 2002;36:255-62.
6. Coburn MC, Carney WI Jr. Comparison of basilic vein and polytetrafluoroethylene for brachial arteriovenous fistula. J Vasc Surg 1994;20:896-902.
7. Kherlakian GM, Roedersheimer LR, Arbaugh JJ, Newmark KJ, King LR. Comparison of autogenous fistula versus expanded polytetrafluoroethylene graft fistula for angioaccess in hemodialysis. Am J Surg 1986;152:238-43.
8. Bayne K. Revised Guide for the Care and Use of Laboratory Animals available. American Physiological Society. Physiologist 1996;39:199, 208-11.
9. Isenberg BC, Williams C, Tranquillo RT. Small-diameter artificial arteries engineered in vitro. Circ Res 2006;98:25-35.
10. Conte MS. The ideal small arterial substitute: a search for the Holy Grail? FASEB J 1998;12:43-5.
11. Quiñones-Baldrich WJ, Prego AA, Ucelay-Gomez R, Freischlag JA, Ahn SS, Baker JD, et al. Long-term results of infrainguinal revascularization with polytetrafluoroethylene: a ten-year experience. J Vasc Surg 1992;16:209-17.
12. Ritter EF, Fata MM, Rudner AM, Klitzman B. Heparin bonding increases patency of long microvascular prostheses. Plast Reconstr Surg 1998;101:142-6.
13. Wong G, Li JM, Hendricks G, Eslami MH, Rohrer MJ, Cutler BS. Inhibition of experimental neointimal hyperplasia by recombinant human thrombomodulin coated ePTFE stent grafts. J Vasc Surg 2008;47:608-15.
14. Schaner PJ, Martin ND, Tulenko TN, Shapiro IM, Tarola NA, Leichter RF, et al. Decellularized vein as a potential scaffold for vascular tissue engineering. J Vasc Surg 2004;40:146-53.
15. Martin ND, Schaner PJ, Tulenko TN, Shapiro IM, Dimatteo CA, Williams TK, et al. In vivo behavior of decellularized vein allograft. J Surg Res 2005;129:17-23.
16. Wagner E, Roy R, Marois Y, Douville Y, Guidoin R. Fresh venous allografts in peripheral arterial reconstruction in dogs. Effects of histocompatibility and of short-term immunosuppression with cyclosporine A and mycophenolate mofetil. J Thorac Cardiovasc Surg 1995;110:1732-44.
17. Allaire E, Guettier C, Bruneval P, Plissonnier D, Michel JB. Cell-free arterial grafts: morphologic characteristics of aortic isografts, allografts, and xenografts in rats. J Vasc Surg 1994;19:446-56.
18. Allaire E, Bruneval P, Mandet C, Becquemin JP, Michel JB. The immunogenicity of the extracellular matrix in arterial xenografts. Surgery 1997;122:73-81.
19. Iaffaldano RA, Lewis BE, Johnson SA, Piffare R, McKiernan TL. Patency of cryopreserved saphenous vein grafts as conduits for coronary artery bypass surgery. Chest 1995;108:725-9.
20. Lopez-Soler RI, Brennan MP, Goyal A, Wang Y, Fong P, Tellides G, et al. Development of a mouse model for evaluation of small diameter vascular grafts. J Surg Res 2007;139:1-6.
21. Atoui R, Asenjo JF, Duong M, Chen G, Chiu RC, Shum-Tim D. Marrow stromal cells as universal donor cells for myocardial regenerative therapy: their unique immune tolerance. Ann Thorac Surg 2008;85:571-9.
22. Traktuev DO, Tsokolaeva ZI, Shevelev AA, Talitskiy KA, Stepanova VV, Johnstone BH, et al. Urokinase gene transfer augments angiogenesis in ischemic skeletal and myocardial muscle. Mol Ther 2007;15:1939-46.
23. Pascual G, Martínez S, Rodríguez M, Serrano N, Bellón JM, Buján J. Patency and structural changes in cryopreserved arterial grafts used as vessel substitutes in the rat. J Surg Res 2005;124:297-304.
24. Lesauskaite V, Tanganelli P, Sassi C, Neri E, Diciolla F, Ivanoviene L, et al. Smooth muscle cells of the media in the dilatative pathology of ascending thoracic aorta: morphology, immunoreactivity for osteopontin, matrix metalloproteinases, and their inhibitors. Hum Pathol 2001;32:1003-11.
25. Ikonomidis JS, Gibson WC, Gardner J, Sweterlitsch S, Thompson RP, Mukherjee R, et al. A murine model of thoracic aortic aneurysms. J Surg Res 2003;115:157-63.